Demir, M., Grünewald, F., Lang, S., Schramm, C., Bowe, A., Mück, V., . . . Steffen, H. (2016). Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients. Wolters Kluwer Health.
Chicago Style CitationDemir, Münevver, Friederike Grünewald, Sonja Lang, Christoph Schramm, Andrea Bowe, Vera Mück, Fabian Kütting, Tobias Goeser, and Hans-Michael Steffen. Elevated Liver Fibrosis Index FIB-4 Is Not Reliable for HCC Risk Stratification in Predominantly Non-Asian CHB Patients. Wolters Kluwer Health, 2016.
MLA CitationDemir, Münevver, et al. Elevated Liver Fibrosis Index FIB-4 Is Not Reliable for HCC Risk Stratification in Predominantly Non-Asian CHB Patients. Wolters Kluwer Health, 2016.
Warning: These citations may not always be 100% accurate.